Cytotoxic effect of a combination of bluetongue virus and radiation on prostate cancer.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25009632)

Published in Exp Ther Med on June 02, 2014

Authors

Wei Wang1, Mei-Nan Chen2, Kai Cheng3, Li-Li Zhan4, Jie Zhang5

Author Affiliations

1: Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
2: Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
3: Huangshi Central Hospital, Hubei Polytechnic University, Huangshi, Hubei 435000, P.R. China.
4: Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
5: Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China ; Huangshi Central Hospital, Hubei Polytechnic University, Huangshi, Hubei 435000, P.R. China.

Articles citing this

Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology (2016) 0.81

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul (1984) 35.22

Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer (2003) 15.17

Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer (2002) 3.17

Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF. Mol Ther (2006) 3.09

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene Ther (2008) 1.88

Systemic reovirus therapy of metastatic cancer in immune-competent mice. Cancer Res (2003) 1.59

Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy. Cancer Res (2002) 1.30

Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells. Cancer Res (2008) 1.30

Targeting cancer-initiating cells with oncolytic viruses. Mol Ther (2009) 1.18

Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic. Cancer Res (2010) 1.16

Oncolytic virotherapy reaches adolescence. Pediatr Blood Cancer (2010) 0.99

The bluetongue viruses. Curr Top Microbiol Immunol (1990) 0.96

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. Br J Cancer (2003) 0.94

AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy. J Gene Med (2007) 0.89

Selective in vitro cytotoxic effect of human cancer cells by bluetongue virus-10. Acta Oncol (2008) 0.86

Intensity modulated radiation therapy (IMRT) in the management of prostate cancer. Cancer Invest (2004) 0.83